Ankon Technologies, developer of a capsule-based gastric cancer diagnostics system, has received funding from investors including SoftBank's Chinese CVC subsidiary.

The Eli Lilly-backed firm has closed its oversubscribed fourth fund, LAV Biosciences Fund IV, reportedly raising the capital in only two months.

Gene therapy developer Krystal has received $7m in funding from Sun Pharmaceutical Industries, in a deal that values the startup at roughly $44m.

Hong Kong X Technology Fund was established to support participants in an accelerator co-founded by professors from HKUST and University of Hong Kong.

The BioMerieux and Stratec-backed medical diagnostics technology provider has raised $8.5m in a T.Rowe Price-led private placement that will be added to a $46m series D round.

Cuorips, a spinout from Osaka University, has sold an option right for the commercialisation of a treatment for severe heart failure to Daiichi Sankyo in return for an undisclosed sum.

University of Plymouth has launched Vaccine Group, a vaccine developer based on research by Michael Jarvis, associate professor in virology and immunology.

Roivant Sciences, which is developing a range of drugs through various subsidiaries, has secured $1.1bn in a round led by the $93bn Vision Fund.

SoftBank China and Legend Capital both participated in a round that the gastrointestinal cancer diagnostics device developer will use to expand its R&D activities.